NASH Core Curriculum: A Comprehensive Online Resource Center

Learn about the impact of NASH and the interplay with diabetes, obesity, and cardiovascular disease.

Brent A. Neuschwander-Tetri, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: February 3, 2021 Expired: February 2, 2022

What Is NASH?

What Is the Relationship Between NASH and Other Metabolic Disturbances?

Is NASH Reversible?

Learn about the impact of NASH and the interplay with diabetes, obesity, and cardiovascular disease.

Brent A. Neuschwander-Tetri, MD Released: February 3, 2021

The pathogenesis of NASH is complex, but there’s insight in looking at diabetes, obesity, and insulin resistance through the lens of the liver.

Brent A. Neuschwander-Tetri, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 29, 2021 Expired: January 28, 2022

Learn about who is at risk and who should be evaluated for progression to advanced fibrosis in NASH.

Manal F. Abdelmalek, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 15, 2021 Expired: March 14, 2022

How Prevalent Are NASH and NASH with Advanced Hepatic Fibrosis?

How Quickly Does NASH Progress?

Who Is at Risk for Progression to Advanced Hepatic Fibrosis?

Learn about who is at risk and should be evaluated for progression to advanced fibrosis in NASH.

Manal F. Abdelmalek, MD, MPH Released: March 15, 2021

AASLD guidelines do not recommend routine screening for NAFLD or NASH, but they and other guidelines do call out patients with type 2 diabetes as warranting workup.

Manal F. Abdelmalek, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 16, 2021 Expired: March 15, 2022

Learn how to use noninvasive tests to identify individuals with NAFLD and determine their risk of progression to NASH fibrosis.

Wing-Kin Syn, MBChB, PhD, FACP, FRCP Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 27, 2021 Expired: April 26, 2022

Introduction

Identifying Individuals With NAFLD

Risk Stratifying NAFLD: Tools to Identify Significant or Advanced Hepatic Fibrosis

Clinical or Laboratory Scores

Proprietary Biomarkers

Imaging

Sequential Tests

Learn the best tools and approaches to identify NAFLD and to rule in or rule out NASH fibrosis.

Wing-Kin Syn, MBChB, PhD, FACP, FRCP Released: April 27, 2021

With the many noninvasive tests available for screening those who are at risk for NAFLD/NASH, where should we begin and what is the optimal sequence of testing? Here’s my approach.

Wing-Kin Syn, MBChB, PhD, FACP, FRCP Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: April 20, 2021 Expired: April 19, 2022